| Medical technology adoption, uncertainty, and irreversibilities: is a bird in the hand really worth more than in the bush? | |
| | |
MedLine Citation:
|
PMID: 19267329 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The influence of current medical technology adoption decisions on the use of future potential interventions is often overlooked. Some health interventions, once exercised, restrict future potential interventions for both related and unrelated medical conditions. For example, treatment of a patient with an antibiotic may lead to resistance in that patient that precludes future treatment with the same or related compounds. This irreversibility raises the value of treatment modalities that preserve future treatment options. Surprisingly, partial reversibility with or without learning can either increase or decrease this value, depending on the distribution of patient types within the treated population. Evaluations that ignore these option values miss an important part of the welfare equation that is becoming increasingly important as individuals live longer and the stock of medical treatments increases. |
| | |
Authors:
|
Joshua Graff Zivin; Matthew Neidell |
Related Documents
:
|
16683499 - Number synaesthesia: when hearing "four plus five" looks like gold. 16533239 - Effect of a single overnight topical application of miconazole nitrate paste on acne pa... 1670069 - The christopher hinton lecture 1990. medical engineering--the multi-disciplinary challe... 17493499 - Peri-anesthetic anaphylaxis. 18303009 - Exploring the potential of constructionist therapy: deaf clients, hearing therapists an... 16602229 - Follow-on biologics: competition in the biopharmaceutical marketplace. 7495459 - A model for predicting heal repayment patterns and its implications for medical student... 10111969 - An examination of physician use of and attitudes toward closed formulary drug programs. 16022319 - Residual activity and population effects of noviflumuron for german cockroach (dictyopt... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Health economics Volume: 19 ISSN: 1099-1050 ISO Abbreviation: Health Econ Publication Date: 2010 Feb |
Date Detail:
|
Created Date: 2010-02-10 Completed Date: 2010-04-29 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9306780 Medline TA: Health Econ Country: England |
Other Details:
|
Languages: eng Pagination: 142-53 Citation Subset: IM |
Copyright Information:
|
Copyright (c) 2009 John Wiley & Sons, Ltd. |
Affiliation:
|
School of International Relations and Pacific Studies, University of California, San Diego, CA, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cost-Benefit Analysis Diffusion of Innovation* Humans Models, Statistical Technology, Medical / economics* Uncertainty* United States |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of...
Next Document: An empirical study of the mechanisms of mindfulness in a mindfulness-based stress reduction program.